Mirando Mrsić

Learn More
Type 1 Gaucher disease is currently categorized as non-neuronopathic, although recent studies suggest peripheral neurological manifestations. We report prevalence and incidence data for peripheral neuropathy and associated conditions from a multinational, prospective, longitudinal, observational cohort study in patients with type 1 Gaucher disease, either(More)
BACKGROUND The absence of neurological symptoms and signs is traditionally considered mandatory for a diagnosis of type 1 Gaucher disease (GD1), but in recent years many reports have emerged on neurological manifestations in GD1 patients. Nevertheless, it has been unclear whether cognitive deficits are part of the disease as well. METHODS Cognitive(More)
to as orphan diseases , have a very low incidence and include diseases that occur at a prevalence of less than 5 cases per 10 000 people in the overall population (1). New rare diseases are discovered every year, and some of today's known diseases in this category have patient populations of fewer than a hundred (2). In a country like Croatia (population of(More)
Aim: Stem cell transplantation from HLA-matched unrelated donor (MUD) is a standard therapy similar to allografting from related donor. Here we present the treatment outcome of MUD transplantation in the University Hospital Center Zagreb. Zagreb 71 patients (average of 28 years, range 1 month to 61 year) underwent MUD transplantation; the reason for(More)
Infections are a major cause of morbidity and mortality in immunocompromised patients. The recognition and treatment of infections in this patient population are particularly diffi cult task for several reasons: the clinical manifestation of infection may be indistinguishable from those of the underlying disease; the effect of im-munosuppressive therapy may(More)
  • 1